Nanox will integrate the CureMetrix advanced AI diagnostics solution into Nanox’s planned cloud-based software platform, Nanox.CLOUD. The goal of screening exams for breast cancer detection is to identify breast abnormalities as early as possible.Understanding the challenges facing radiologists who read mammograms, CureMetrix has developed AI-based computer-aided diagnostic (CAD) solutions that assist radiologists in detecting cancer earlier and help reduce unnecessary biopsies.
Companies aim to provide new medical imaging standard of care to rural areas as well as major cities. According to the agreement, Gateway agrees to guarantee a minimum service fee of $58 million per year for three years to Nanox.
The companies will collaborate on the deployment of 3,000 Nanox Systems in the U.S., under Nanox’s MSaaS (Medical Screening as a Service) pay-per-scan business model, which the Company expects will make medical imaging more accessible to patients at affordable costs.
Foxconn is joining strategic investors Fujifilm and SK Telecom who have previously invested in the project. This round brings Nanox to a total of $55M funding to support the development of the Nanox System. The funding is expected to enable Nanox to continue its mission to expand early detection of medical conditions that are discoverable by X-ray.
The mmedical imaging technology company, introduces the first commercial-grade digital X-ray technology based on a proprietary silicon MEMs semiconductor technology. This technology is introduced after 15 years of “under the radar” Japanese and Israeli development and substantial investment to overcome one of the biggest barriers to modern medical imaging. This novel digital X-ray source may enable a significant reduction in the cost of medical imaging systems, with the goal of making medical imaging more accessible and available globally.